GBX 0
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for ECO Animal Health Group in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a -100.00% upside from the last price of GBX 338.
The current consensus among 1 contributing investment analysts is to buy stock in ECO Animal Health Group. This Buy consensus rating has held steady for over two years.
ECO Animal Health Group plc develops and markets pharmaceutical products for animals worldwide. The company offers Aivlosin, a macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry. It also provides generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle. The company was founded in 1972 and is headquartered in New Malden, the United Kingdom.
Read More